… barriers to incorporating pharmacogenomic testing into clinical practice and considers how
these barriers … ; many barriers to clinical implementation of pharmacogenomic testing have …

… barriers to adoption of PGx testing: evidence for clinical utility, evidence for economic
effectiveness, and stakeholder awareness. We consider these barriers … in these medical practices. …

… Barriers to adoption of pharmacogenetic tests into practice are substantial and … implementation,
and few physicians and health systems actually use pharmacogenetics in clinical practice…

… barriers to implementing pharmacogenomics in the clinic has … or cost-effectiveness on the
clinical outcome, which would … of pharmacogenomics or find it relevant for clinical practice. …

… pathways, other barriers may be attributed to local … exerted to implement PGx into routine
clinical practice. These … and applying PGx in hospital clinical practice. We then discuss …

… knowledge required for clinical practice and the need for … issues, combined with the lack of
a unique repository within the EHR for storing these data, present a barrier to their clinical use…

… in initiatives to expand the clinical use of pharmacogenomics. First, widespread availability
of … has stated, “Culture trumps strategy,” suggesting that many barriers can be overcome by …

… pharmacogenomics research and genotyping technology, implementation of pharmacogenomics
into clinical practice … of such potential barriers may allow your implementation team to …

… barriers for implementation [4, 6, 10, 13, 20]. In order to integrate PM in clinical practice, these
barriers … Therefore, we must be able to identify existing barriers in Europe. Currently, the …

… This study identified and examined barriers and facilitators to active implementation of a …
receive PGx education are often early adopters of PGx testing within a clinical setting [34,46,47]. …